ABSTRACT Background: n-3 (omega-3) Polyunsaturated fatty acids (PUFAs), fish, and nuts can regulate inflammatory processes and responses. Objective: We investigated whether dietary intakes of PUFAs [n23,, and a-linolenic acid], fish, and nuts were associated with 15-y mortality attributed to noncardiovascular, noncancer inflammatory diseases. Design: The analyses involved 2514 participants aged 49 y at baseline. Dietary data were collected by using a semiquantitative food-frequency questionnaire, and PUFA, fish, and nut intakes were calculated. Inflammatory disease mortality was confirmed from the Australian National Death Index. Results: Over 15 y, 214 subjects died of inflammatory diseases. Women in the highest tertiles of total n23 PUFA intake, compared with those in the lowest tertile of intake at baseline, had a 44% reduced risk of inflammatory disease mortality (P for trend = 0.03). This association was not observed in men. In both men and women, each 1-SD increase in energy-adjusted intake of a-linolenic acid was inversely associated with inflammatory mortality (hazard ratio: 0.83; 95% CI: 0.71, 0.98). Subjects in the second and third tertiles of nut consumption had a 51% and 32% reduced risk of inflammatory disease mortality, respectively, compared with those in the first tertile (reference). Dietary intakes of long-chain n23 and n26 PUFAs and fish were not associated with inflammatory disease mortality. Conclusions: We report on a novel link between dietary intake of total n23 PUFA and risk of inflammatory disease mortality in older women. Furthermore, our data indicate a protective role of nuts, but not fish, against inflammatory disease mortality.
INTRODUCTION
Inflammation is part of the normal host response to infection and injury and is characterized by the production of inflammatory cytokines, eicosanoids, adhesion molecules, and other inflammatory mediators (1) . Some of the causes of death and disability are characterized by exaggerated inflammation and excessive formation of inflammatory eicosanoids and cytokines (2) . Examples of such conditions and diseases include chronic obstructive pulmonary diseases, rheumatoid arthritis, asthma, and inflammatory bowel disease (2) .
Many studies have investigated the potential of long-chain n23 polyunsaturated fatty acids (PUFAs) to attenuate excessive inflammation in most of the known inflammatory diseases and conditions (1) . Fish contain n23 PUFAs [particularly eicosapentaenoic acid (EPA) and docosahexaenoic acid (DHA)], which have been shown to regulate inflammatory processes and responses (1) . The long-chain n23 PUFAs EPA and DHA, as found in oily fish and fish oils, have been shown to decrease the production of inflammatory mediators (eg, cytokines and reactive oxygen species) and the expression of adhesion molecules (1) . Evidence of the clinical benefits of long-chain n23 PUFAs is strong in some settings (eg, rheumatoid arthritis) yet weak in others (eg, in asthma and inflammatory bowel disease) (1) . Similarly, nuts are rich in unsaturated fats and other nutrients, which are also thought to decrease concentrations of inflammatory markers (3).
Jacobs et al (4) introduced a new method of classifying mortality from noncardiovascular disease (CVD) and noncancer inflammatory disease, specifically focusing on diseases for which inflammation or oxidative stress is the key pathophysiologic factor (5) . Given the antiinflammatory properties of dietary PUFAs, fish, and nuts, we investigated whether intakes of these nutritional components were associated with death attributed to this novel characterization of inflammatory diseases (4) . Specifically, we used a large representative, population-based cohort of older adults to pursue the following aims: 1) to establish whether dietary intakes of PUFA (n23, n26, and a-linolenic acid) were associated with 15-y inflammatory disease mortality and 2) whether a diet high in fish or nuts was associated with a reduced risk of inflammatory mortality.
SUBJECTS AND METHODS

Study population
The current report is based on the Blue Mountains Eye Study, a population-based study of participants aged 49 y, living in 2 postcodes of the Blue Mountains region, west of Sydney, Australia, which studied age-related eye diseases and other health outcomes in an older urban Australian population. Details of the study methods were previously described (6) . In brief, during 1992-1994, 3654 participants aged 49 y were examined (82.4% participation; BMES-1). Surviving baseline participants were invited to attend 5-y follow-up examinations (1997-1999, BMES-2); 2335 participants (75.1% of survivors) were examined. At the 10-y follow-up (2002) (2003) (2004) , BMES-3), 1952 participants (75.6% of survivors) were reexamined. The study was approved by the Human Research Ethics Committee of the University of Sydney and was conducted adhering to the tenets of the Helsinki Declaration. Signed informed consent was obtained from all participants at each examination.
Dietary assessment
Dietary data were collected by using a 145-item self-administered food-frequency questionnaire (FFQ), which was modified for the Australian diet and vernacular from an early Willett FFQ (7) and included reference portion sizes. Participants used a 9-category frequency scale to indicate the usual frequency of consuming individual food items during the past year. The FFQ included details about frequency estimates and fatty acid supplements and was used to permit a more detailed analysis of fatty acids.
We extracted separate data on the frequency of consuming any type of fish and nuts. Approximately 1 serving of fish and nuts is equivalent to 145 and 20 g, respectively. Fish and nut consumption was converted to grams per day by multiplying the food-consumption frequency by fixed portion sizes. The FFQ was validated in 79 participants, ie, 4-d weighed food records were collected on 3 occasions over 1 y (8) . The FFQ showed moderateto-good agreement for ranking individuals according to their fat intakes (total fat: r = 0.68; saturated fatty acids: r = 0.67; monounsaturated fatty acids: r = 0.54; polyunsaturated fatty acids: r = 0.44) and correctly classified .70% of persons within 1 quintile for all types of fat (8, 9) .
Dietary intakes were estimated by using the Australian Tables of Food Composition (NUTTAB95) (9) and its fatty acid supplement. Additional fatty acid food-composition data were added from the Royal Melbourne Institute of Technology database (10), available on FoodWorks (version 3; Xyris Software Pty Ltd, Highgate Hill, Australia). Long chain n23 PUFAs were calculated from the sum of EPA (20:5n23), docosapentaenoic (DPA, 22:5 n23), and DHA (22:6n23). Total n23 PUFA consumption was calculated by adding the intakes of long-chain n23 PUFAs and a-linolenic acid. All dietary sources of n-3 PUFAs were included in the analyses. This is based on dietary intake from many sources. In previously published fatty acid food sources of this population (11), we described the various food sources. For total n-3 PUFA intake, the main dietary sources were from fats and oils (27%), fish and seafood (21%), meat and meat products (13%), breads and cereals (8%), milk and milk products (8%); the main food sources of long-chain n-3 fats were fish and seafood (69%), meat and meat products (15%), and eggs (15%; includes n-3-fortified eggs). The FFQ includes specific questions about type of oil and margarine, which are individually coded and included in the total PUFA analyses. This analysis of the baseline dietary intake does not include n-3 from supplements. Previous investigations have indicated supplement use of n-3/fish oils was not high in this cohort (12) . The total n-6 PUFA consumption was calculated by adding the intakes of linoleic and arachidonic acid.
Mortality from inflammatory diseases
Mortality data since baseline (15 y) were obtained via data linkage with the Australian National Death Index (NDI) in December 2007. Information provided by family members during follow-up was also included if the participant was reported to have died on or before December 2007. The major underlying cause of death recorded by the NDI was used to identify inflammatory disease-related causes of deaths ( Table 1 ). The validity of Australian NDI data has been reported to have high sensitivity and specificity for total mortality (93.7% and 100%, respectively) (13) As proposed by Jacobs et al (4) , non-CVD, noncancer inflammatory diseases that had an inflammatory, oxidative stress, or infectious component as the predominant pathophysiology were considered inflammatory diseases. As in the study by Jacobs et al, we excluded cardiovascular diseases from the inflammatory categorization because other mechanisms (eg, deposition of atherosclerotic plaque) are likely to be at least as important causes of mortality in these diseases (4). We followed their scheme and examined each international classification of disease code that occurred in our sampled. The causes of death (by disease groups) that we considered to be related to inflammatory diseases were previously described for the BMES (5) and are shown in Table 1 . Our analyses were made on the basis of these causes of death listed in Table 1 .
Assessment of covariates
Body mass index (BMI) was calculated from measured weight (in kg) and height squared (in m), and a BMI 25 was defined as overweight and ,18.5 as underweight. At face-to-face interviews with trained interviewers, a comprehensive medical history that included information about demographic factors, socioeconomic characteristics, and lifestyle factors such as smoking were obtained from all participants. History of smoking was defined as never, past, or current smoking. Current smokers included those who had stopped smoking within the past year. Alcohol intake was assessed by questions about the frequency of consuming alcoholic drinks (d/wk), and consumption was split into 3 groups (no alcohol, 0-20 g/d, or .20 g/d). A history of angina, myocardial infarction, diabetes mellitus, hypertension, stroke, or cancer at baseline was determined by responses to questions starting with "Has a doctor advised you that you have . . . ?" Because the examined associations could be confounded by the use of antiinflammatory medication, information on all currently taken medications was considered to determine the use of systemic corticosteroids and nonsteroidal antiinflammatory drugs. Fasting blood samples were processed on the same day for serum lipids, plasma glucose concentrations, white blood cell count, and fibrinogen at the Westmead Hospital Clinical Pathology laboratory, in Western Sydney, Australia. Diabetes was defined as either a history of the disease or a fasting blood glucose concentration 7.0 mmol/L.
Statistical analysis
SAS statistical software (version 9.1; SAS Institute, Cary, NC) was used for the analyses. The association between dietary intakes of PUFAs, fish, and nuts and inflammatory disease mortality were examined with Cox regression models to estimate hazard ratios (HRs) and 95% CIs. Dietary fatty acid intakes were energy-adjusted by using the residual method described by Willett and Stampfer (14) . Multivariable regression models were first adjusted for age and sex and were then further adjusted for confounders that were found to be significantly associated with inflammatory disease mortality, ie, BMI (overweight and underweight), current smoking status, alcohol consumption (no alcohol, 0-20 g/d, or .20 g/d), poor self-rated health, presence of diabetes, corticosteroid drug use, dietary glycemic index, total fiber intake, and white blood cell count. We studied the intake of PUFAs, fish, and nuts as categorized (tertiles; the lowest tertile was used as the reference group) and as continuous (per SD) variables. We also tested for statistically significant interactions between dietary PUFAs and sex by adding a product term in the final multivariable model. We defined an interaction if the association between the joint variable of dietary PUFAs and sex departed from the multiplicative scale of the association between each factor alone, confirmed by a statistically significant interaction term. Significance was set at P , 0.05.
RESULTS
Of the 3654 participants examined at BMES-1, 2897 participants had complete dietary data. Of these, 362 coronary heart disease or stroke mortality cases were excluded from the analyses. An additional 21 subjects were excluded because they did not have cause of death information available, which left 2514 participants for mortality analyses. During the 15-y follow-up there were 214 (8.5%) cases for which the major underlying cause was attributed to inflammatory diseases. The baseline characteristics of our study sample were stratified by tertiles of total n23 PUFA intake ( Table 2 ). In summary, participants within the highest tertiles of total n23 PUFA intake compared with those in the lowest tertiles were younger, were more likely to eat fish and nuts, were more moderate drinkers, and had lower mean dietary glycemic index and energy intakes ( Table 2) .
The interaction term between total n23 PUFAs and sex for inflammatory disease mortality was marginally significant (P for interaction = 0.05); hence, when assessing the association with total n23 fatty acids, we stratified the analyses by sex. After multivariable adjustment, women in the highest tertile of total n23 PUFA intake compared with those in the lowest tertile of intake at baseline had a 44% reduced risk of dying from inflammatory-related diseases during the subsequent 15 y (P for trend = 0.03; Table 3 ). A significant association with total n23 PUFA was not observed in men.
The interaction term between long-chain n23 PUFAs and sex for inflammatory disease mortality was not significant (P for interaction = 0.17). Hence, in men and women separately, after multivariable adjustment, no significant association was found between dietary intake of long-chain n23 PUFAs and inflammatory disease mortality (P for trend = 0.53 and 0.19, respectively). Because no sex interaction was observed with any of the other dietary variables of interest (data not shown), we did not stratify these analyses by sex. Hence, all other data are presented for men and women combined. The dietary intakes of long-chain n23 PUFAs, a-linolenic acid, and total n26 PUFAs (by tertiles) were not associated with inflammatory disease mortality in the BMES ( Table 4) . We further explored the association between dietary intakes of PUFA (as a continuous variable) and inflammatory disease mortality. In multivariableadjusted linear regression models, each 1-SD increase in energyadjusted intake of a-linolenic acid was associated with a 17% lower risk of dying from inflammatory diseases (multivariableadjusted HR: 0.83; 95% CI: 0.71, 0.98). However, no continuous adjusted linear relation was observed between the intakes of other PUFAs and inflammatory disease mortality (data not shown).
The association between consumption of either fish or nuts at baseline and the risk of inflammatory disease mortality over the next 15 y is shown in Table 5 . BMES participants who were in the second and third tertiles of nut consumption had a 51% and 32% reduced risk of inflammatory disease mortality, respectively, compared with participants in the lowest tertile of consumption. However, the trend was not significant, which indicated a threshold effect. Fish in the diet was not associated with the risk of dying from inflammatory diseases ( Table 5) .
The 15-y survival of BMES participants in each tertile of nut consumption is shown in Figure 1A , and survival in each tertile of total n23 PUFA intake in women is shown in Figure 1B . Older persons in the lowest tertile of nut consumption had lower survival rates than did those in the upper 2 quartiles. Similarly, women in the lowest tertile of total n23 fatty acids intake had lower survival rates than did women in the upper 2 tertiles.
DISCUSSION
This report provides novel epidemiologic evidence on the association between inflammatory disease mortality and dietary intake of PUFAs, fish, and nuts. In this older cohort, women in the higher tertiles compared with those in the lower tertiles of total n23 intake had a 43% reduced risk of dying from noncardiovascular, noncancer inflammatory diseases. This protective effect was not observed in men. In addition, each 1-SD increase in energy-adjusted intake of a-linolenic acid was associated with a 17% decreased risk of dying from inflammatory diseases. Moreover, high consumption of nuts at baseline was protective against 15-y inflammatory disease mortality. In contrast, however, neither long-chain n23 PUFAs nor fish intake reduced the risk of chronic inflammation-related mortality.
The association between total n23 PUFAs and reduced risk of inflammatory disease mortality expands on previous observations that dietary PUFAs attenuate excessive inflammation in most of the known inflammatory conditions (1). To explain our results, we drew on findings from the Nurses' Health Study of 727 women aged 43-69 y (15). C-reactive protein concentrations (a marker of systemic inflammation) were 29% lower 
TABLE 3
Hazard ratios (95% CIs) for 15-y inflammatory disease mortality by tertile (T) range of dietary fatty acid intake in women (n = 1437) and men (n = 1077) among those in the highest quintile of total n23 fatty acid intake, compared with the lowest quintile; interleukin-6 concentrations were 23% lower and E-selectin concentrations 10% lower. A potential biochemical pathway by which total n23 fatty acids attenuate inflammation and endothelial activation is by reducing the baseline production of hydrogen peroxide (16) . Hydrogen peroxide is a critical activator of the nuclear transcription factor jB system of transcription factors, which controls the expression of, for example, adhesion molecules on cytokine stimulation (15) . The sex-specific difference in the current study was most likely not attributable to different ranges in nutritional intake in the BMES, as shown previously (5) . This indicates that other underlying mechanisms could account for these differences. Evidence suggests that older women are more sensitive to the ability of n23 PUFAs to reduce the production of inflammatory cytokines (17); such a pronounced effect was not observed in older men (2, 18) . Furthermore, women have lower plasma total antioxidant activity than men (19) . Because autoimmune disorders (eg, rheumatoid arthritis and systemic lupus) are more common in women than in men (20) , this increase in baseline risk could result in a larger absolute risk reduction in women than in men exposed to the same dietary influences. Finally, in the BMES, '50% of the inflammatory disease mortality cases in men were due to respiratory diseases (eg, chronic obstructive pulmonary disease and asthma), and the number was significantly greater than in women (P = 0.01). Given that n23 fatty acid intake does not have a major protective effect on respiratory health (21, 22) , 3 Cox regression model further adjusted for current smoking, alcohol consumption, poor self-rated health, BMI, presence of diabetes, total fiber, dietary glycemic index, use of corticosteroid drugs, and white blood cell count. it could explain to some extent the nonsignificant association with total n23 PUFA on inflammatory disease mortality in men.
The lack of an association between 15-y inflammatory disease mortality and long-chain n23 PUFAs and fish was surprising, but concurs with 2 recent reviews that showed that the effects of long-chain n23 PUFAs on inflammatory markers are not very solid (2, 23, 24) . We cannot exclude that random misclassification of fish consumption contributed to a dilution of a true association with this nutritional factor (25, 26) . Furthermore, we investigated mortality, not incidence, of inflammatory diseases. Hence, it is possible that associations between mortality and long-chain n23 PUFA and fish intakes do not reflect the initial inflammatory events. Also, participants may have changed their diets or medications after receiving advice from health professionals (eg, arthritis patients are often advised to take fish-oil supplements to reduce joint swelling); these changes could have attenuated the association between inflammatory mortality and long-chain n23 PUFA and fish intakes. Because n23 fatty acids may compete with n26 PUFA for conversion to eicosanoids (27, 28) , high linoleic acid could lessen the antiinflammatory effects of long-chain n23 PUFAs. However, no association was observed between the n23 to n26 fatty acid ratio and risk of dying from inflammatory diseases in this study.
Although we adjusted for many potential confounders, we cannot exclude the possibility that our data were subject to residual confounding from other lifestyle or dietary factors closely correlated with fish intake, which could have masked any true associations. For example, a protective effect of n23 fatty acids from fish could have been missed if the fish consumed by BMES participants was mainly fried (28) . Fried fish intake was shown to be positively associated with concentrations of inflammatory markers, eg, C-reactive protein; hence, we hypothesize that the benefit of a high consumption of fish could be nullified by its preparation method (29) . However, detailed information on the cooking method for fish was not available in the BMES, so we cannot confirm this hypothesis.
In the BMES, increasing the consumption of nuts by as little as 1.4 g day (ie, from the first to the second tertiles) was associated with a reduced 49% risk of dying from chronic inflammationrelated diseases. Increasing consumption of nuts above the first tertile only conferred a slightly higher protection, which indicated a threshold effect. This protective effect of nuts concurs with a cross-sectional study of 6000 participants (3) in which soluble inflammatory markers decreased across increasing categories of nut consumption. Several bioactive components in nuts, acting in isolation or most probably synergistically, could explain the beneficial effects on inflammation (30) . Magnesium, a mineral found in nuts at higher amounts than in other edible plants (31) , could contribute to the reduction of inflammatory markers (30) . Furthermore, dietary polyphenols present in nuts may have antiinflammatory effects, mediated by both their antioxidant action and modulation of signal transduction pathways (30) .
Nuts also contain PUFAs, including a-linolenic acid and linoleic acid. a-Linolenic acid has been shown to exert favorable effects on cytokine production; this fatty acid has also shown to significantly decrease cell adhesion molecules, including E-selectin (32) . Additionally, a-linolenic acid has been shown to have similar inverse associations with inflammatory biomarkers and endothelial activation as fish (n23) fatty acids (15) . This concurs with our finding of a 17% reduced risk of inflammatory mortality with a linear increase in intake of a-linolenic acid. Because a-linolenic acid is the most frequently consumed n23 fatty acid in Western diets, our data suggest that dietary intake of a-linolenic acid, specifically at higher intakes than currently consumed, could be a simple-to-implement antiinflammatory intervention (32) .
The key strengths of our study included the representative population-based sample, the relatively high participation rate, minimization of selection bias, availability of rich covariate/ confounder information, and the use of standardized protocols for exposure and outcome assessment. However, some limitations of the current study warrant consideration. First, dietary assessment by FFQ in which respondents have to estimate typical intake frequencies of food items and their portion sizes can potentially introduce measurement error and bias. Although we cannot rule out this possibility, the validity of fatty acid categories compared with weighted food records was moderately good overall (8, 9, 12) . Second, we could have underestimated the causes of death due to inflammation, because violent death, cardiovascular disease, and cancer may be preferentially coded as the major underlying cause if these conditions coexisted with inflammatory disease-related death (5) . Nevertheless, the classification by Jacobs et al (4) appears to identify causes of death that are more purely dependent on inflammation or oxidative processes than on cardiovascular disease, which thus permits more specific insights into the likely relevance of dietary factors for inflammatory diseases (5) . Third, we did not validate the cause of death; hence, the underlying cause could have been misclassified to some extent.
In summary, in women, increased dietary intake of total n23 fatty acids could contribute to an appreciable reduction in the risk of noncardiovascular, noncancer inflammatory disease mortality. Modest consumption of nuts conferred a protective effect against inflammatory disease mortality; several bioactive components present in nuts may account for this beneficial effect. A higher intake of long-chain n23 PUFAs and fish was not associated with a decreased risk of inflammatory disease mortality. The reasons for this are not clear and require confirmation in other large population-based cohorts. These studies will also be useful in establishing whether dietary fatty acids and nuts have a role in the prevention of chronic inflammation-related mortality.
